Photo from Susan G. Komen/X
Jun 5, 2024, 12:51
Susan G. Komen: Tarah Ballinger presents results from the EAZ171 trial at ASCO24
Tarah Ballinger, Assistant Professor of Clinical Medicine at Indiana University School of Medicine, shared a post by Susan G. Komen, on X/Twitter, adding:
”Thank you Susan G. Komen for your support!!”
Quoting Susan G. Komen’s post:
”Komen grantee Tarah Ballinger presents results from the EAZ171 trial at ASCO24. The results showed that docetaxel resulted in less grade 2 neuropathy, a painful side effect from some chemotherapy drugs, than paclitaxel for Black women.”
Source: Tarah Ballinger/X and Susan G. Komen/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 20, 2024, 01:07
Nov 20, 2024, 01:00
Nov 20, 2024, 00:40
Nov 20, 2024, 00:31
Nov 20, 2024, 00:29